For the first time in the UK, robotic technology is being used to support genomic testing for cancer patients following a partnership between The Royal Marsden NHS Foundation Trust and Automata ...

Genetic testing identifies germline mutations, while genomic testing analyzes somatic mutations in tumors, influencing treatment options. Broader testing criteria are expanding access to genetic ...

Genomic classifier (GC) tests do not appear to consistently influence risk classification or treatment decisions for patients with newly diagnosed prostate cancer considering first-line treatment, ...

Genomic testing is pivotal in refining breast cancer treatment strategies, particularly for African American women facing unique diagnostic challenges. Tests like MAMMAPRINT analyze numerous genes, ...

Broad genomic profiling was used in only 1 in 4 US patients with newly diagnosed metastatic cancer between 2020 and 2022, a new study reported. Although testing rates increased over this time period, ...

Genomic testing matters in endometrial cancer both for prognostication and therapeutic selection, but there's work to do in making sure it reaches all women. "It is a very exciting time for ...

Vivek Subbiah, MD, considers artificial intelligence (AI) and comprehensive somatic and germline testing essential for guiding precision oncology and improving patient care. Vivek Subbiah, MD, chief ...

Tens of thousands of patients with lung cancer in the United Kingdom are missing out on targeted treatment that could improve their prognosis due to delays in genomic testing, a new report has warned.